- Avista Healthcare Partners has completed its previously announced acquisition of Germany-based vitamins, minerals, and supplements company sanotact Group.
- The acquisition adds a CDMO business with formulation and dosage capabilities alongside sanotact’s branded products portfolio to Avista’s consumer healthcare investments.
Avista Healthcare Partners has completed its previously announced acquisition of Sanotact Group GmbH, a Germany-based vitamins, minerals, and supplements (VMS) company with operations spanning both CDMO and branded products. The acquisition expands Avista’s consumer healthcare portfolio and adds its ninth platform investment in the sector.
Founded and headquartered in Münster, Germany, sanotact provides contract manufacturing services with formulation and dosage capabilities while also marketing branded consumer healthcare products in Germany and international markets. According to Avista, the company has established customer relationships and a track record of product innovation that support future growth.
Avista said the acquisition adds scale to its consumer healthcare portfolio and positions the business for continued expansion through product innovation and targeted mergers and acquisitions. The transaction also extends the firm’s relationship with the Damier Group as part of its strategy to build consumer health businesses in Europe.
The company stated that sanotact combines a contract development and manufacturing business with an established branded presence in the German market and a growing international footprint. Financial terms of the completed transaction were not disclosed.
